Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative panitumumab with radiotherapy in locally advanced rectal cancer
2009-011325-14Phase 2Terminated
- Sponsor
- Cliniques universitaires Saint-Luc
- Start
- May 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of panitumumab in rectal cancer and rectal adenocarcinoma, sponsored by Cliniques universitaires Saint-Luc. Primary endpoint: Pathological complete response. Started May 2009; status: terminated.
02
Drugs
panitumumab
03
Conditions
rectal cancerrectal adenocarcinoma
Beyond the preview
Go deeper on 2009-011325-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011325-14.